作者: Corine Bertolotto-Ballotti , Robert Ballotti , Sandy Giuliano , Mickael Ohanna
DOI:
关键词:
摘要: The present invention relates to products and compositions containing (i) a chemotherapeutic agent (ii) at least an active compound chosen from CCL2 inhibitors, CCR2 NF-κB PARP-1 inhibitors ATM as combined preparation for simultaneous, separate or sequential use inhibiting tumor development caused by cell senescence induced said agent. also refers method monitoring the response of patient suffering cancer, predicting size evolution and/or onset metastasis in cancer.